CEL-SCI Corporation (CVM)
NYSEAMERICAN: CVM · Real-Time Price · USD
2.380
+0.020 (0.85%)
Jun 6, 2025, 4:00 PM - Market closed

CEL-SCI Market Cap

CEL-SCI has a market cap or net worth of $12.22 million as of June 6, 2025. Its market cap has decreased by -82.76% in one year.

Market Cap
12.22M
Enterprise Value
20.82M
1-Year Change
-82.76%
Ranking
Category
Stock Price
$2.38

Market Cap Chart

Since December 1, 1998, CEL-SCI's market cap has decreased from $1.63T to $12.22M, a decrease of -100.00%. That is a compound annual growth rate of -35.90%.

History

DateMarket Cap% Change
Jun 6, 20257.20M-70.73%
Dec 31, 202424.60M-81.90%
Dec 29, 2023135.90M32.46%
Dec 30, 2022102.60M-66.58%
Dec 31, 2021307.00M-33.78%
Dec 31, 2020463.60M43.22%
Dec 31, 2019323.70M297.18%
Dec 31, 201881.50M226.00%
Dec 29, 201725.00M96.85%
Dec 30, 201612.70M-73.60%
Dec 31, 201548.10M-9.42%
Dec 31, 201453.10M80.61%
Dec 31, 201329.40M-60.16%
Dec 31, 201273.80M10.81%
Dec 30, 201166.60M-60.45%
Dec 31, 2010168.40M25.11%
Dec 31, 2009134.60M300.60%
Dec 31, 200833.60M-42.37%
Dec 31, 200758.30M27.85%
Dec 29, 200645.60M25.27%
Dec 30, 200536.40M-16.13%
Dec 31, 200443.40M-99.97%
Dec 31, 2002143.38B-77.89%
Dec 31, 2001648.64B-36.67%
Dec 29, 20001,024.17B-35.06%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 691.15B
Johnson & Johnson 373.01B
AbbVie 335.32B
Novo Nordisk 332.47B
UnitedHealth Group 275.06B
Abbott Laboratories 232.41B
Novartis AG 231.17B
AstraZeneca 226.14B
Market Cap Rankings